Knihovna kufru tygr houba na mytí overall immunosuppressive burden účinnost horní zlomenina
IKKα-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines | PNAS
Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-κB signaling pathway in CD4 T cells: Molecular Therapy
Tumor mutational burden and immunotherapy in gliomas: Trends in Cancer
Steering Transplant Immunosuppression by Measuring Virus-Specific T Cell Levels: The Randomized, Controlled IVIST Trial | American Society of Nephrology
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy | Nature Reviews Clinical Oncology
High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy | SpringerLink
Frontiers | Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
The need for minimization strategies: current problems of immunosuppression - Bamoulid - 2015 - Transplant International - Wiley Online Library
PDF) High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored?
Cancer Risk Among Immunosuppressed Populations - NCI
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative - The Lancet Rheumatology
Frontiers | Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
Systemic immunity in cancer | Nature Reviews Cancer
Mutational burden, MHC-I expression and immune infiltration as limiting factors for in situ vaccination by TNFα and IL-12 gene electrotransfer - ScienceDirect
Frontiers | Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression
JCM | Free Full-Text | Post-Transplant Cyclophosphamide and Tacrolimus—Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA ...
Immunosuppressive Therapy and Risk Stratification of Patients With Myocarditis Presenting With Ventricular Arrhythmias - ScienceDirect
Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote immunosuppression in pancreatic cancer - eBioMedicine
Frontiers | Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation - ScienceDirect
Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations - eBioMedicine
Targeting immunosuppressive adenosine in cancer | Nature Reviews Cancer
Immunosuppression - an overview | ScienceDirect Topics
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text
Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive microenvironment with high mutational burden in lung cancer | Journal for ImmunoTherapy of Cancer
Managing immunosuppressive therapy in potentially cured post‐kidney transplant cancer (excluding non‐melanoma skin cancer): an overview of the available evidence and guidance for shared decision‐making - Hellemans - 2021 - Transplant International -